Table. Patient Demographic Characteristics.
| Patient number | Sex | Age range, y | Race | Onset of DM, y | Type of DM | History of malignancy | Previous treatments | Concurrent treatments with apremilast |
|---|---|---|---|---|---|---|---|---|
| 1 | Woman | 60-69 | White | 2013 | Classic | No | Azathioprine, MMF, MTX, rituximab | Hydroxychloroquine, IVIG, prednisone 15 mg daily |
| 2 | Man | 50-59 | White | 2011 | Amyopathic | No | Azathioprine, hydroxychloroquine, MTX, prednisone | MMF |
| 3 | Woman | 60-69 | White | 2012 | Classic | Yes, for ovarian and anal cancer | Hydroxychloroquine, IVIG, MTX, prednisone | Hydroxychloroquine, IVIG, MTX, prednisone 3mg every other day |
| 4 | Woman | 70-79 | White | 2006 | Amyopathic | No | Azathioprine, MMF, MTX, prednisone | Hydroxychloroquine |
| 5 | Woman | 60-69 | White | 2012 | Classic | No | Azathioprine, MTX | Hydroxychloroquine, MMF, prednisone 5 mg daily |
| 6 | Woman | 18-19 | White | 2017 | Juvenile | No | Hydroxychloroquine, MMF, MTX, prednisone | Hydroxychloroquine, MMF, MTX |
| 7 | Woman | 50-59 | White | 2015 | Classic | No | MTX, Prednisone, rituximab | Hydroxychloroquine, MMF |
| 8 | Woman | 40-49 | White | 2014 | Amyopathic | No | MMF, Prednisone | Hydroxychloroquine, MTX |
Abbreviations: DM, dermatomyositis; IVIG, intravenous immunoglobulin; MMF, mycophenolate mofetil; MTX, methotrexate.